So far, research trials havent prompted regulatory agencies to approve these substances or convinced companies to invest in further development
After a subcutaneous injection, semaglutide reaches its peak blood concentration between one and three days
This method, based on the Kolmogorov-Smirnov (KS) like random walk statistic, allows to produce a bimodal distribution of enrichment scores by generating non-zero maximum deviations under the null distribution
The term GLP-1 refers to the hormone glucagon-like peptide-1, which is naturally produced in the gut after meals and helps regulate appetite, digestion, and insulin release
Retatrutide (LY3437943) is an investigational triple GLP-1, GIP, and glucagon receptor agonist developed by Eli Lilly, with Phase 2 clinical data published in 2023 showing dose-dependent body weight reductions and HbA1c improvements